← Home
The Indicator from Planet Money · June 26, 2026 · 8m

GLP-1 and women, the AI office boom, and RTO: CEO ego?

Show Notes

This episode of The Indicator unpacks three market and workplace snapshots: how GLP-1 weight-loss drugs may uniquely affect women and reshape labor-force participation; the rebound of New York City's office market, fueled in part by AI and tech demand; and the provocative hypothesis that CEOs who mandate a return to the office may display narcissistic traits. The short episode flags emerging trends without deep dives, offering quick economic signals.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Highlights

•
GLP-1s reshape women's workplace participation
GLP-1 drugs are having a notable effect on women's health and may be altering how and whether women engage with the workforce.
ClaudeChatGPTGemini
•
AI office boom revives NYC commercial real estate
New York City's once-struggling office market is making a comeback, driven partly by demand from artificial intelligence and tech companies.
ClaudeChatGPTGemini
•
RTO mandates linked to CEO narcissism
The push to return to the office might be more about CEO ego than productivity, according to the episode's discussion of personality research.
ClaudeChatGPTGemini
Was this useful?